Biogen, Ionis terminates development of ALS investigational drug
Topline results from the Phase 1/2 ALSpire study indicated no reduction in levels of plasma neurofilament light chain (NfL), a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.